1
|
Lohitha N, Vijayakumar V. Imidazole Appended Novel Phenoxyquinolines as New Inhibitors of α-Amylase and α-Glucosidase Evidenced with Molecular Docking Studies. Polycycl Aromat Compd 2021. [DOI: 10.1080/10406638.2021.1939069] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- N. Lohitha
- Centre for Organic and Medicinal Chemistry, VIT University, Vellore, India
| | - V. Vijayakumar
- Centre for Organic and Medicinal Chemistry, VIT University, Vellore, India
| |
Collapse
|
2
|
da Silva SEB, da Silva Moura JA, de Sousa Nunes TR, da Rocha Pitta I, da Rocha Pitta MG. New Trends On Biological Activities And Clinical Studies Of Quinolinic Analogues: A Review. Curr Drug Targets 2021; 23:441-457. [PMID: 33858312 DOI: 10.2174/1389450122666210415100151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2020] [Revised: 12/24/2020] [Accepted: 02/02/2021] [Indexed: 11/22/2022]
Abstract
The quinolinic ring, present in several molecules, has a great diversity of biological activities. Therefore, this ring is in the structure composition of several candidates of drugs in preclinical and clinical studies, thus, it is necessary the grouping of these results to facilitate the design of new drugs. For this reason, some of the activities were selected for this review, such as: antimalarial, antimicrobial, anticancer, anti-inflammatory, antidiabetic, anti-rheumatic and antiviral. All publications of scientific articles chosen are dated between 2000 and 2020. In addition to presenting the structures of some natural and synthetic compounds with their activities, we list the clinical studies of phases III and IV of antimalarial drugs containing the quinoline nucleus and phase III clinical studies of hydroxychloroquine and chloroquine to assess their possible role in COVID-19. Finally, we show some of the mechanisms of action, as well as the side effects of some of the quinolinic derivatives.
Collapse
Affiliation(s)
- Sandra Elizabeth Barbosa da Silva
- Laboratory of Design and Drug Synthesis (LPSF), Nucleus of Research in Therapeutical Innovation Suely Galdino (NUPIT SG), Biosciences Center, Federal University of Pernambuco, Recife. Brazil
| | - José Arion da Silva Moura
- Laboratory of Design and Drug Synthesis (LPSF), Nucleus of Research in Therapeutical Innovation Suely Galdino (NUPIT SG), Biosciences Center, Federal University of Pernambuco, Recife. Brazil
| | - Tiago Rafael de Sousa Nunes
- Laboratory of Design and Drug Synthesis (LPSF), Nucleus of Research in Therapeutical Innovation Suely Galdino (NUPIT SG), Biosciences Center, Federal University of Pernambuco, Recife. Brazil
| | - Ivan da Rocha Pitta
- Laboratory of Design and Drug Synthesis (LPSF), Nucleus of Research in Therapeutical Innovation Suely Galdino (NUPIT SG), Biosciences Center, Federal University of Pernambuco, Recife. Brazil
| | - Marina Galdino da Rocha Pitta
- Laboratory of Design and Drug Synthesis (LPSF), Nucleus of Research in Therapeutical Innovation Suely Galdino (NUPIT SG), Biosciences Center, Federal University of Pernambuco, Recife. Brazil
| |
Collapse
|
3
|
Sri Ramya P, Guntuku L, Angapelly S, Karri S, Digwal CS, Babu BN, Naidu V, Kamal A. Curcumin inspired 2-chloro/phenoxy quinoline analogues: Synthesis and biological evaluation as potential anticancer agents. Bioorg Med Chem Lett 2018; 28:892-898. [DOI: 10.1016/j.bmcl.2018.01.070] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2017] [Revised: 01/29/2018] [Accepted: 01/31/2018] [Indexed: 10/18/2022]
|
4
|
Sunke R, Nallapati SB, Kumar JS, Shiva Kumar K, Pal M. Use of AlCl3 in Friedel Crafts arylation type reactions and beyond: an overview on the development of unique methodologies leading to N-heteroarenes. Org Biomol Chem 2017; 15:4042-4057. [DOI: 10.1039/c7ob00468k] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
An overview on the development of unique methodologies that highlight the use of AlCl3 in reactions leading to new N-heteroarenes of biological significance is presented.
Collapse
Affiliation(s)
- Rajnikanth Sunke
- Dr Reddy's Institute of Life Sciences
- Hyderabad Central University
- Hyderabad-500 046
- India
| | - Suresh Babu Nallapati
- Dr Reddy's Institute of Life Sciences
- Hyderabad Central University
- Hyderabad-500 046
- India
| | - Jetta Sandeep Kumar
- Dr Reddy's Institute of Life Sciences
- Hyderabad Central University
- Hyderabad-500 046
- India
| | - K. Shiva Kumar
- Department of Chemistry
- Osmania University
- Hyderabad-500 007
- India
| | - Manojit Pal
- Dr Reddy's Institute of Life Sciences
- Hyderabad Central University
- Hyderabad-500 046
- India
| |
Collapse
|
5
|
Li YS, Tian H, Zhao DS, Hu DK, Liu XY, Jin HW, Song GP, Cui ZN. Synthesis and bioactivity of pyrazole and triazole derivatives as potential PDE4 inhibitors. Bioorg Med Chem Lett 2016; 26:3632-5. [DOI: 10.1016/j.bmcl.2016.06.002] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2016] [Revised: 05/18/2016] [Accepted: 06/02/2016] [Indexed: 11/30/2022]
|
6
|
Serya RAT, Abbas AH, Ismail NSM, Esmat A, Abou El Ella DA. Design, Synthesis and Biological Evaluation of Novel Quinazoline-Based Anti-inflammatory Agents Acting as PDE4B Inhibitors. Chem Pharm Bull (Tokyo) 2015; 63:102-16. [DOI: 10.1248/cpb.c14-00737] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
| | - Abeer Hussin Abbas
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ain Shams University
| | | | - Ahmed Esmat
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University
| | | |
Collapse
|
7
|
Marella A, Tanwar O, Saha R, Alam MM, Zaman MS, Akhter M. 3D quantitative structure–activity relationship for quinoline, benzimidazole and benzofuran-based analogs as phosphodiesterases IV (PDE-IV) inhibitors. Med Chem Res 2013. [DOI: 10.1007/s00044-012-0457-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
8
|
Ting PC, Lee JF, Kuang R, Cao J, Gu D, Huang Y, Liu Z, Aslanian RG, Feng KI, Prelusky D, Lamca J, House A, Phillips JE, Wang P, Wu P, Lundell D, Chapman RW, Celly CS. Discovery of oral and inhaled PDE4 inhibitors. Bioorg Med Chem Lett 2013; 23:5528-32. [PMID: 24018187 DOI: 10.1016/j.bmcl.2013.08.056] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2013] [Accepted: 08/13/2013] [Indexed: 12/20/2022]
Abstract
The optimization of oxazole-based PDE4 inhibitor 1 has led to the identification of both oral (compound 16) and inhaled (compound 34) PDE4 inhibitors. Selectivity against PDE10/PDE11, off target screening, and in vivo activity in the rat are discussed.
Collapse
Affiliation(s)
- Pauline C Ting
- Department of Chemical Research, Merck Research Laboratories, 126 E. Lincoln Ave., Rahway, NJ 07065, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Mukherjee S, Pal M. Quinolines: a new hope against inflammation. Drug Discov Today 2013; 18:389-98. [DOI: 10.1016/j.drudis.2012.11.003] [Citation(s) in RCA: 65] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2012] [Revised: 10/12/2012] [Accepted: 11/07/2012] [Indexed: 01/05/2023]
|
10
|
|
11
|
Kumar KS, Kiran Kumar S, Yogi Sreenivas B, Gorja DR, Kapavarapu R, Rambabu D, Rama Krishna G, Reddy CM, Basaveswara Rao M, Parsa KV, Pal M. C–C bond formation at C-2 of a quinoline ring: Synthesis of 2-(1H-indol-3-yl)quinoline-3-carbonitrile derivatives as a new class of PDE4 inhibitors. Bioorg Med Chem 2012; 20:2199-207. [DOI: 10.1016/j.bmc.2012.02.027] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2012] [Revised: 02/07/2012] [Accepted: 02/08/2012] [Indexed: 12/31/2022]
|
12
|
Ochiai K, Takita S, Eiraku T, Kojima A, Iwase K, Kishi T, Fukuchi K, Yasue T, Adams DR, Allcock RW, Jiang Z, Kohno Y. Phosphodiesterase inhibitors. Part 3: Design, synthesis and structure–activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-dihydropyridazinones with anti-inflammatory and bronchodilatory activity. Bioorg Med Chem 2012; 20:1644-58. [DOI: 10.1016/j.bmc.2012.01.033] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2011] [Revised: 01/19/2012] [Accepted: 01/19/2012] [Indexed: 11/24/2022]
|
13
|
Takács A, Szilágyi A, Ács P, Márk L, Peixoto AF, Pereira MM, Kollár L. Palladium-catalysed reactions of 8-hydroxy- and 8-benzyloxy-5,7-diiodoquinoline under aminocarbonylation conditions. Tetrahedron 2011. [DOI: 10.1016/j.tet.2011.02.003] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
14
|
Takács A, Abreu AR, Peixoto AF, Pereira M, Kollár L. Synthesis ofOrtho-alkoxy-aryl Carboxamides via Palladium-Catalyzed Aminocarbonylation. SYNTHETIC COMMUN 2009. [DOI: 10.1080/00397910802542028] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Attila Takács
- a Department of Inorganic Chemistry , University of Pécs , Pécs, Hungary
| | - Artur R. Abreu
- b Departamento de Quimica , Universidade de Coimbra , Coimbra, Portugal
| | | | - Mariette Pereira
- b Departamento de Quimica , Universidade de Coimbra , Coimbra, Portugal
| | - László Kollár
- a Department of Inorganic Chemistry , University of Pécs , Pécs, Hungary
| |
Collapse
|
15
|
Press NJ, Banner KH. PDE4 inhibitors - a review of the current field. PROGRESS IN MEDICINAL CHEMISTRY 2009; 47:37-74. [PMID: 19328289 DOI: 10.1016/s0079-6468(08)00202-6] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Neil J Press
- Novartis Institutes for Biomedical Research, Horsham, West Sussex RH12 5AB, UK
| | | |
Collapse
|
16
|
Kodimuthali A, Jabaris SSL, Pal M. Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease. J Med Chem 2008; 51:5471-89. [PMID: 18686943 DOI: 10.1021/jm800582j] [Citation(s) in RCA: 129] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Arumugam Kodimuthali
- New Drug Discovery, R & D Center, Matrix Laboratories Limited, Anrich Industrial Estate, Bollaram, Jinnaram Mandal, Medak District, Andhra Pradesh, 502 325, India
| | | | | |
Collapse
|
17
|
Kuang R, Shue HJ, Blythin DJ, Shih NY, Gu D, Chen X, Schwerdt J, Lin L, Ting PC, Zhu X, Aslanian R, Piwinski JJ, Xiao L, Prelusky D, Wu P, Zhang J, Zhang X, Celly CS, Minnicozzi M, Billah M, Wang P. Discovery of a highly potent series of oxazole-based phosphodiesterase 4 inhibitors. Bioorg Med Chem Lett 2007; 17:5150-4. [PMID: 17683932 DOI: 10.1016/j.bmcl.2007.06.092] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2007] [Revised: 06/28/2007] [Accepted: 06/29/2007] [Indexed: 10/23/2022]
Abstract
Substituted quinolyl oxazoles were discovered as a novel and highly potent series of phosphodiesterase 4 (PDE4) inhibitors. Structure-activity relationship studies revealed that the oxazole core, with 4-carboxamide and 5-aminomethyl groups, is a novel PDE4 inhibitory pharmacophore. Selectivity profiles and in vivo biological activity are also reported.
Collapse
Affiliation(s)
- Rongze Kuang
- Department of Chemical Research, Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Traditional and modern approaches to the synthesis of quinoline systems by the Skraup and Doebner-Miller methods. (Review). Chem Heterocycl Compd (N Y) 2006. [DOI: 10.1007/s10593-006-0150-y] [Citation(s) in RCA: 76] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
19
|
Microwave promoted solvent-free one-pot three-component reaction to 2-pentafluorophenylquinoline derivatives. Tetrahedron Lett 2004. [DOI: 10.1016/j.tetlet.2004.04.179] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
20
|
Billah M, Cooper N, Cuss F, Davenport RJ, Dyke HJ, Egan R, Ganguly A, Gowers L, Hannah DR, Haughan AF, Kendall HJ, Lowe C, Minnicozzi M, Montana JG, Naylor R, Oxford J, Peake JC, Piwinski JJ, Runcie KA, Sabin V, Sharpe A, Shih NY, Warneck JBH. Synthesis and profile of SCH351591, a novel PDE4 inhibitor. Bioorg Med Chem Lett 2002; 12:1621-3. [PMID: 12039576 DOI: 10.1016/s0960-894x(02)00225-1] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The syntheses and pharmacological profiles of some 2-trifluoromethyl-8-methoxyquinoline-5-carboxamides are described. SCH351591 is a potent selective inhibitor of phosphodiesterase type 4 (PDE4).
Collapse
Affiliation(s)
- Motasim Billah
- Schering-Plough Corporation, Galloping Hill Road, Kenilworth, NJ 07033-0530, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|